ULC

~{O}-(5,6,7,8-tetrahydronaphthalen-2-yl) ~{N}-(6-methoxypyridin-2-yl)-~{N}-methyl-carbamothioate

Created:	2023-02-07
Last modified:	2024-02-21

Find Related PDB Entry
1 entries where ULC is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	43
Chiral Atom Count	0
Bond Count	45
Aromatic Bond Count	12

2D diagram of ULC

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	~{O}-(5,6,7,8-tetrahydronaphthalen-2-yl) ~{N}-(6-methoxypyridin-2-yl)-~{N}-methyl-carbamothioate
Systematic Name (OpenEye OEToolkits)	~{O}-(5,6,7,8-tetrahydronaphthalen-2-yl) ~{N}-(6-methoxypyridin-2-yl)-~{N}-methyl-carbamothioate
Formula	C₁₈ H₂₀ N₂ O₂ S
Molecular Weight	328.429
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	CACTVS	3.385	COc1cccc(n1)N(C)C(=S)Oc2ccc3CCCCc3c2
SMILES	OpenEye OEToolkits	2.0.7	CN(c1cccc(n1)OC)C(=S)Oc2ccc3c(c2)CCCC3
Canonical SMILES	CACTVS	3.385	COc1cccc(n1)N(C)C(=S)Oc2ccc3CCCCc3c2
Canonical SMILES	OpenEye OEToolkits	2.0.7	CN(c1cccc(n1)OC)C(=S)Oc2ccc3c(c2)CCCC3
InChI	InChI	1.06	InChI=1S/C18H20N2O2S/c1-20(16-8-5-9-17(19-16)21-2)18(23)22-15-11-10-13-6-3-4-7-14(13)12-15/h5,8-12H,3-4,6-7H2,1-2H3
InChIKey	InChI	1.06	VPHPQNGOVQYUMG-UHFFFAOYSA-N

Drug Info: DrugBank

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

DrugBank ID	DB19985
Name	Liranaftate
Groups	experimental
Description	Liranaftate is a small molecule drug. Liranaftate has a monoisotopic molecular weight of 328.12 Da.
Synonyms	Piritetrate Liranaftate
Categories	Acids, Acyclic Antifungals for Dermatological Use Antifungals for Topical Use Carbamates Dermatologicals Naphthalenes Sulfur Compounds Thiocarbamates
ATC-Code	D01AE25
CAS number	88678-31-3

Related Resource References

Resource Name	Reference
PubChem	3936
ChEMBL	CHEMBL1591365
ChEBI	CHEBI:31775

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729. RCSB PDB uses resources of the National Energy Research Scientific Computing Center (NERSC), a Department of Energy User Facility.